Australia markets closed

Kiromic BioPharma, Inc. (KRBP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.3000-0.6100 (-20.96%)
At close: 03:22PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-20,949
-20,949
-34,731
-25,589
-19,200
Depreciation & amortisation
2,221
2,221
1,673
469.8
200
Stock-based compensation
141.3
141.3
1,237
3,763
13,246
Change in working capital
-3,213
-3,213
4,370
710.3
-394.5
Accounts receivable
0
0
16.2
9.8
0
Inventory
-
-
-
-
0
Accounts payable
-5,035
-5,035
3,791
1,411
-7.7
Other working capital
-21,432
-21,432
-28,626
-22,216
-7,584
Other non-cash items
574.8
574.8
3,718
-
0.2
Net cash provided by operating activities
-21,225
-21,225
-23,746
-20,321
-6,127
Cash flows from investing activities
Investments in property, plant and equipment
-206.6
-206.6
-4,880
-1,895
-1,458
Net cash used for investing activities
-206.6
-206.6
-4,865
-1,811
-1,458
Cash flows from financing activities
Debt repayment
-557.2
-557.2
-508
-573.7
-188.1
Common stock issued
659.1
659.1
0
40,000
15,000
Other financing activities
-111.2
-111.2
-200
-2,882
-2,667
Net cash used provided by (used for) financing activities
23,991
23,991
3,903
37,336
15,806
Net change in cash
2,559
2,559
-24,709
15,203
8,221
Cash at beginning of period
645.2
645.2
25,354
10,151
1,929
Cash at end of period
3,204
3,204
645.2
25,354
10,151
Free cash flow
Operating cash flow
-21,225
-21,225
-23,746
-20,321
-6,127
Capital expenditure
-206.6
-206.6
-4,880
-1,895
-1,458
Free cash flow
-21,432
-21,432
-28,626
-22,216
-7,584